Publikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (188)

2024

  1. Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

    Journal of Endocrinological Investigation, Vol. 47, Núm. 6, pp. 1405-1418

  2. Coronavirus disease 2019 is associated with long-term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome

    Psychological Medicine, Vol. 54, Núm. 3, pp. 620-630

  3. Dietary intake of Perfluorooctanesulfonic acid (PFOS) and glucose homeostasis parameters in a non-diabetic senior population

    Environment International, Vol. 186

  4. Effect of a nutritional intervention based on an energy-reduced Mediterranean diet on environmental impact

    Science of the Total Environment, Vol. 928

  5. Impact of mediterranean diet promotion on environmental sustainability: a longitudinal analysis

    Public Health, Vol. 230, pp. 12-20

  6. Long-term association between water intake and kidney function in a population at high cardiovascular risk

    Journal of Nutrition, Health and Aging, Vol. 28, Núm. 9

  7. Microbial Phenolic Metabolites Are Associated with Improved Cognitive Health

    Molecular Nutrition and Food Research, Vol. 68, Núm. 2

  8. More Adult Women than Men at High Cardiometabolic Risk Reported Worse Lifestyles and Self-Reported Health Status in the COVID-19 Lockdown

    Nutrients, Vol. 16, Núm. 13

  9. Polyphenols and metabolism: from present knowledge to future challenges

    Journal of Physiology and Biochemistry

  10. Response to Letter to the Editor Clinical Nutrition

    Clinical Nutrition

  11. Sex-specific dietary patterns and their association with metabolic syndrome: Insights from a cross-sectional analysis

    Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 18, Núm. 9

  12. Telomere length and 4-year changes in cognitive function in an older Mediterranean population at high risk of cardiovascular disease

    Age and ageing, Vol. 53, Núm. 10

  13. The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model

    Pediatric Drugs, Vol. 26, Núm. 3, pp. 331-346